Volume 15 Issue 2 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Volume 15 Issue 2

The Future of AI in Biotechnology

On the Precipice of the New Technological Revolution The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms lik...

3 July 2023 Volume 15 Issue 2 AI | artificial

Continue Reading →

Volume 15 Issue 2

Cutting-edge Formulation is Needed to Enable the Next Generation of Oral Biologics

An Introduction to Oral Solid Dose Traditionally, the pharmaceutical market has been dominated by oral drug delivery – whether oral solid dose (OSD) or liquid suspen...

3 July 2023 Volume 15 Issue 2 biologics | cutting-edge

Continue Reading →

Volume 15 Issue 2

Individual Device Identification: Coding and Marking for the New Dimension in Patient Health and Safety

Counterfeit products and product piracy are serious issues for the pharmaceutical industry – but recent product marking requirements in developed economies, includin...

3 July 2023 Volume 15 Issue 2 coding | Counterfeit

Continue Reading →

Volume 15 Issue 2

Potent Product Manufacturing in a Multi-product Facility

Highly potent drugs are becoming increasingly common in the drug development pipeline. The focus on oncology, rare diseases, and targeted therapies is grow...

3 July 2023 Volume 15 Issue 2 development | drug

Continue Reading →

Volume 15 Issue 2

Effective Operations for Risk Reduction and Supply Chain Resilience

There is no denying that the market for injectable drug delivery devices is growing rapidly, with forecasts predicting an increase from $39.93 billion in 2022 to $43...

3 July 2023 Volume 15 Issue 2 chain | delivery

Continue Reading →

Volume 15 Issue 2

Choosing and Developing User-friendly Osmotic Laxatives for a More Patient-centric Portfolio

At least 1 in 10 people worldwide suffer from constipation at some point in their lives.1,2 It affects people of all ages and has many causes. The symptoms of consti...

3 July 2023 Volume 15 Issue 2 abdomen | affects

Continue Reading →

Volume 15 Issue 2

Artificial Intelligence is a Core Pillar in the Evolution of Digital Health and Patient-centric Solutions

The US Food & Drug Administration has stated that digital technology is driving a revolution in healthcare. The lines between healthcare delivery and clinical re...

3 July 2023 Volume 15 Issue 2 artificial | clinical

Continue Reading →

Volume 15 Issue 2

Net Zero Healthcare – Priorities for Decarbonising the Pharma Supply Chain

The climate and our health are inextricably linked. The effects of climate change on global health systems and outcomes are already clear, with WHO proclaiming it to...

3 July 2023 Volume 15 Issue 2 chain | change

Continue Reading →

Volume 15 Issue 2

Harnessing the Power of cMaaS in Pharma Logistics

Ensuring Regulatory Compliance and Sustainable Supply Chain Management End-to-end digital visibility across the supply chain can be used to identify hotspots, sup...

3 July 2023 Volume 15 Issue 2 chain | compliance

Continue Reading →

Volume 15 Issue 2

Why an Outcome-driven Approach to Supply Chain is a Strategic Advantage for Pharmaceutical Businesses

Since 2020, the pharmaceutical industry has been grappling with frequent and rapid changes, shifting customer demands and increasing costs. In response, organisation...

3 July 2023 Volume 15 Issue 2 approach | Businesses

Continue Reading →

Future-ready ADCs – advanced vial solutions for superior stability and performance

Alternative Drug Delivery Routes: Opportunities, Challenges, and How to Overcome Them

Bridging the gap between R&D and GMP

Current Edition

Current Edition

Subsection - CDMO

Subsection - Injectables

Subsection - Neurodegenerative Diseases

Subsection - Nasal & Pulmonary

The Future of AI in Biotechnology

Cutting-edge Formulation is Needed to Enable the Next Generation of Oral Biologics

Individual Device Identification: Coding and Marking for the New Dimension in Patient Health and Safety

Potent Product Manufacturing in a Multi-product Facility

Effective Operations for Risk Reduction and Supply Chain Resilience

Choosing and Developing User-friendly Osmotic Laxatives for a More Patient-centric Portfolio

Artificial Intelligence is a Core Pillar in the Evolution of Digital Health and Patient-centric Solutions

Net Zero Healthcare – Priorities for Decarbonising the Pharma Supply Chain

Harnessing the Power of cMaaS in Pharma Logistics

Why an Outcome-driven Approach to Supply Chain is a Strategic Advantage for Pharmaceutical Businesses

International Pharmaceutical Industry